However, circNRIP1 plays an oncogenic role in RCC, which activates adenylate-activated protein kinase (AMPK) and PI3K/AKT/mTOR pathways by targeting miR-505 (Dong et al., 2020). Here, MTOR is linked to renal cell carcinoma.